Switchability Criteria
Switchability Criteria is a methodological framework within bioequivalence assessment that specifies the conditions under which interchangeable use of pharmaceutical products can be deemed therapeutically equivalent and safe for patient switching without adverse clinical outcomes.
21
Publications
650
Citations
68
Authors
43
Institutions
Publications per year
2017–2026
6
21
Types of bioequivalence and related statistical considerations.
Walter W. Hauck, Stewart Anderson · PubMed · 1992 · 80 citations
An individual bioequivalence criterion: regulatory considerations
Mei‐Ling Chen, Rabindra Patnaik, Walter W. Hauck et al. · Statistics in Medicine · 2000 · 61 citations
1–5 of 21
68
3
h-index
3
h-index
3
h-index
2
h-index
2
h-index
1–5 of 68
43

Thomas Jefferson University
Philadelphia, United States
3 h-index
4 publications
258 citations

Université Fédérale de Toulouse Midi-Pyrénées
Toulouse, France
3 h-index
14 publications
383 citations

University of London
London, United Kingdom
2 h-index
3 publications
96 citations

Royal Veterinary College
London, United Kingdom
2 h-index
4 publications
112 citations

École Nationale Vétérinaire de Toulouse
Toulouse, France
2 h-index
10 publications
280 citations
Centre Hospitalier Universitaire de Toulouse
Toulouse, France
2 h-index
2 publications
56 citations
CNR de la Résistance aux Antibiotiques
Besançon, France
2 h-index
10 publications
280 citations
Innovations Thérapeutiques et Résistances
Toulouse, France
2 h-index
10 publications
280 citations
1–8 of 43
6 publications · 299 citations
6
h-index
2 publications · 56 citations
2
h-index
IJBC · 2 publications · 25 citations
2
h-index
AJHP · 1 publications · 12 citations
1
h-index
1 publications · 14 citations
1
h-index
1–5